Inhibition of c-Abl tyrosine kinase activity by filamentous actin

被引:92
|
作者
Woodring, PJ [1 ]
Hunter, T
Wang, JYJ
机构
[1] Salk Inst, La Jolla, CA 92037 USA
[2] Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA
关键词
D O I
10.1074/jbc.M100559200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The catalytic activity of c-Abl tyrosine kinase is reduced in fibroblasts that are detached from the extracellular matrix. We report here that a deletion of the extreme C terminus of c-Abl (DeltaF-actin c-Abl) can partially restore kinase activity to c-Abl from detached cells. Because the extreme C terminus of c-Abl contains a consensus F-actin binding motif, we investigated the effect of F-actin on c-Abl tyrosine kinase activity. We found that F-actin can inhibit the kinase activity of purified c-Abl protein. Mutations of the extreme C-terminal region of c-Abl disrupted both the binding of c-Abl to F-actin and the inhibition of c-Abl by F-actin. Mutations of the SH3, SH2, and DNA binding domains did not abolish the inhibition of c-Abl kinase by F-actin. Catalytic domain substitutions that affect the regulation of c-Abl by the retinoblastoma protein or the ataxia telangiectasia-mutated kinase also did not abolish the inhibition of c-Abl by F-actin. Interestingly, among these c-Abl mutants, only the DeltaF-actin c-Abl retained kinase activity in detached cells. Taken together, the data suggest that F-actin is an inhibitor of the c-Abl tyrosine kinase and that this inhibition contributes in part to the reduced Abl kinase activity in detached cells.
引用
收藏
页码:27104 / 27110
页数:7
相关论文
共 50 条
  • [21] Nuclear-cytoplasmic shuttling of C-ABL tyrosine kinase
    Taagepera, S
    McDonald, D
    Loeb, JE
    Whitaker, LL
    McElroy, AK
    Wang, JYJ
    Hope, TJ
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (13) : 7457 - 7462
  • [22] Activation of c-Abl tyrosine kinase induces chromatin condensation
    Aoyama, Kazumasa
    Fukumoto, Yasunori
    Hattori, Yasuyuki
    Takahashi, Akinori
    Kubota, Sho
    Morinaga, Takao
    Nakayama, Yuji
    Yamaguchi, Naoto
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2008, 128 : 89 - 90
  • [23] Functional role for the c-Abl tyrosine kinase in meiosis I
    Kharbanda, S
    Pandey, P
    Morris, PL
    Whang, Y
    Xu, YH
    Sawant, S
    Zhu, LJ
    Kumar, N
    Yuan, ZM
    Weichselbaum, R
    Sawyers, CL
    Pandita, TK
    Kufe, D
    ONCOGENE, 1998, 16 (14) : 1773 - 1777
  • [24] Activated c-Abl tyrosine kinase in malignant solid tumors
    Lin, J.
    Arlinghaus, R.
    ONCOGENE, 2008, 27 (32) : 4385 - 4391
  • [25] c-Abl tyrosine kinase regulates cardiac growth and development
    Qiu, Zhaozhu
    Cang, Yong
    Goff, Stephen P.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (03) : 1136 - 1141
  • [26] c-Abl tyrosine kinase and inhibition by the cancer drug imatinib (Gleevec/STI-571)
    Nagar, Bhushan
    JOURNAL OF NUTRITION, 2007, 137 (06): : 1518S - 1523S
  • [27] Activation of protein kinase C δ by the c-Abl tyrosine kinase in response to ionizing radiation
    Zhi-Min Yuan
    Taiju Utsugisawa
    Takatoshi Ishiko
    Shuji Nakada
    Yinyin Huang
    Surender Kharbanda
    Ralph Weichselbaum
    Donald Kufe
    Oncogene, 1998, 16 : 1643 - 1648
  • [28] Activation of protein kinase C δ by the c-Abl tyrosine kinase in response to ionizing radiation
    Yuan, ZM
    Utsugisawa, T
    Ishiko, T
    Nakada, S
    Huang, YY
    Kharbanda, S
    Weichselbaum, R
    Kufe, D
    ONCOGENE, 1998, 16 (13) : 1643 - 1648
  • [29] ABI-2, A NOVEL SH3-CONTAINING PROTEIN INTERACTS WITH THE C-ABL TYROSINE KINASE AND MODULATES C-ABL TRANSFORMING ACTIVITY
    DAI, ZH
    PENDERGAST, AM
    GENES & DEVELOPMENT, 1995, 9 (21) : 2569 - 2582
  • [30] Adhesion signalling through C-Abl and Bcr-Abl tyrosine kinase.
    Wang, JYJ
    Taagepera, S
    Woodring, PJ
    Eidenmuller, WC
    Lam, T
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 703 - 703